Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	723	753	716	571	970	-	-
Market Cap Growth	-	5.29%	25.30%	-41.09%	-	-	-
Enterprise Value	679	707	672	537	946	26	48
PE Ratio	-64.29	-64.29	49.19	31.42	21.06	-	-
PS Ratio	2.65	2.76	3.27	2.53	3.75	-	-
PB Ratio	3.10	3.10	3.29	2.61	4.33	-	-
P/FCF Ratio	-36.19	-36.19	31.91	18.54	10.07	-	-
P/OCF Ratio	-39.19	-39.19	29.95	13.28	9.51	-	-
EV/Sales Ratio	2.49	2.59	3.07	2.38	3.66	0.12	0.31
EV/EBITDA Ratio	162.48	162.59	22.42	11.07	14.81	0.40	5.68
EV/EBIT Ratio	-52.97	-52.97	42.15	20.47	17.60	0.44	49.17
EV/FCF Ratio	-33.95	-33.95	29.97	17.43	9.83	0.32	1.11
Debt / Equity Ratio	0.78	0.78	0.81	0.84	1.02	0.83	1.98
Debt / EBITDA Ratio	43.84	43.84	5.92	3.79	3.57	1.68	16.51
Debt / FCF Ratio	-9.15	-9.15	7.91	5.97	2.37	1.36	3.22
Quick Ratio	3.33	3.33	3.94	4.75	3.15	0.90	1.19
Current Ratio	4.06	4.06	4.65	5.33	3.43	1.05	1.40
Asset Turnover	0.56	0.56	0.52	0.51	0.63	0.81	-
Return on Equity (ROE)	-5.10%	-5.10%	6.80%	8.60%	25.10%	45.30%	-
Return on Assets (ROA)	-2.40%	-2.40%	3.40%	4.10%	11.20%	17.20%	-
Return on Capital (ROIC)	-1.38%	-1.38%	4.48%	2.65%	17.61%	24.62%	601.51%
Earnings Yield	-1.62%	-1.56%	2.03%	3.18%	4.75%	-	-
FCF Yield	-2.77%	-2.76%	3.13%	5.39%	9.93%	-	-
Buyback Yield / Dilution	-1.61%	-1.61%	-1.55%	-0.12%	-	-	-
Total Shareholder Return	-1.61%	-1.61%	-1.55%	-0.12%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).